课题基金 / 基金详情

Development of Fluorescent False Neurotransmitters

Development of Fluorescent False Neurotransmitters
荧光假神经递质的开发
批准号:
9069526
负责人:
DALIBOR SAMES
金额:
$54.54万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-18 至 2020-02-29
关键词:
Action PotentialsAcuteAddressAmphetaminesAnxietyAreaArousalAttentionAttention deficit hyperactivity disorderAxonBehavioralBiologicalBiological AssayBrainBrain DiseasesCalciumCell Culture TechniquesCellsCentral Nervous System DiseasesCharacteristicsCognitionCollaborationsCorpus striatum structureCoupledDataDevelopmentDiseaseDisease modelDopamineDorsalDrug AddictionDrug abuseElectric StimulationEmotionsFiberFluorescenceFutureHealthHippocampus (Brain)ImageImageryIndividualInterdisciplinary StudyKineticsLabelLaboratoriesLeadLearningLibrariesLifeMeasuresMental DepressionMental disordersMethodsMolecular ProbesMonitorMood DisordersMusNeurobiologyNeuronsNeurosciencesNeurotransmittersNorepinephrineOperative Surgical ProceduresOpticsOrganic ChemistryParkinson DiseasePathologyPharmaceutical PreparationsPhasePhysiologicalPlayPreparationPresynaptic TerminalsProcessPropertyRegulationResearchRewardsRodentRodent DiseasesRoleSchizophreniaSensorySerotoninSignal TransductionSliceSomatosensory CortexStagingStressSubstantia nigra structureSynapsesSynaptic VesiclesSynaptic plasticitySystemTimeTracerVaricosityVentral Tegmental Areaarea striatabarrel cortexcalcium indicatordensitydesigndopamine systemdopamine transporterdopaminergic neuronimaging agentimaging modalityin vivoin vivo imagingmedian forebrain bundlemethod developmentmicroscopic imagingmonoaminemulti-photonnervous system disorderneural circuitneurochemistryneuronal cell bodyneuropsychiatric disorderneurotransmissionneurotransmitter releasenoradrenaline transporternovelnovel strategiesoptical imagingoptogeneticspresynapticprogramsreceptorresearch studysensorserotonin transportersomatosensorysynaptic functiontooltool developmenttreatment effectvesicular monoamine transporter 2voltage

项目摘要

项目成果

DALIBOR SAMES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Monoamine neurotransmitters (dopamine, norepinephrine, and serotonin) play important roles in modulating the strength of both excitatory and inhibitory neurotransmission via activation of the corresponding receptors. Monoamine neurons project their axons throughout the brain and regulate diverse brain functions including arousal, stress, emotion, reward, learning, and cognition. On a cellular level, monoamines modulate responsiveness of the target cells and synapses. Aberrations in monoamine neurotransmission have been implicated in numerous neurological and neuropsychiatric disorders including Parkinson's disease, schizophrenia, ADHD, drug addiction, depression, and anxiety. However, due to methodological limitations, monoamine neurotransmission have only been studied on the bulk level of large ensembles of monoaminergic synapses. There have been no experimental tools to examine the monoamine release characteristics of individual presynaptic boutons, a fundamental physiological parameter. Drs. Dalibor Sames (PI-1) and David Sulzer (PI-2) established an interdisciplinary research program focused on addressing this challenge. Specifically, optical probes termed "Fluorescent False Neurotransmitters" (FFNs) were designed as tracers of dopamine. This new application aims to expand the scope of the FFN concept to the entire monoamine system, many different brain areas, and living rodents. We propose to develop FFN probes selective for norepinephrine and serotonin synapses, and in vivo microscopic imaging methods applicable in living rodents. The proposed new imaging methods will enable, for the first time, visualization of synaptic content release at individual presynaptic terminals of specific neurochemical types in vivo in several brain areas (striatum, somatosensory cortex, hippocampus). These new probes and associated imaging methods will unlock the possibility of addressing many long-standing questions about release properties of single synapses and their physiological regulation and deregulation in rodent disease models. The FFN probes are compatible with the existing calcium and voltage sensors and thus jointly these tools will provide a more complete readout of synaptic function and plasticity in intact circuitry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
Chemistry and Pharmacology of Iboga Alkaloids
Chemical Targeting of Sensors and Pharmacological Probes in the Brain
Chemistry and Pharmacology of Iboga Alkaloids
海外基金